Trial intelligence / Profile preview

Effect of a GnRH Injection on Ghrelin Concentrations in Girls With Suspected Precocious Puberty

NCT02431416Completed

Sponsor
Region Örebro län
Start
May 2015
Primary completion
Dec 2017
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Randomised trial of gonadorelin in precocious puberty (2 arms), sponsored by Region Örebro län. Primary endpoint: Ghrelin concentration after GnRH injection and after saline injection. Started May 2015; status: completed.

02

Drugs

gonadorelin
03

Conditions

precocious puberty

Beyond the preview

Go deeper on NCT02431416.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02431416.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call